APP Pharma gets US FDA nod for additional dosages of Granisetron HCl injection APP Pharmaceuticals, Inc., a leading manufacturer of multi-source and branded injectable pharmaceutical products, has received final approvals from the US Food and Drug Administration (FDA) of its Abbreviated New Drug Applications (ANDAs)...
APP Pharmaceuticals Receives Final Approvals for Additional Dosages of Granisetron Hydrochloride Injection, US Company Now Markets Full LineSCHAUMBURG, Ill.--(HSMN NewsFeed)--APP Pharmaceuticals, Inc.(Nasdaq:APPX ), a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced that it has received final...
APP wins approval for additional dosages of generic Kytril injection APP Pharmaceuticals has received final approvals from the FDA of its abbreviated new drug applications for Granisetron hydrochloride injection, 1mg/ml, 1ml single dose, and 1mg/ml, 4ml multiple dose vials, the generic equivalent of...
APP wins approval for additional dosages of generic Kytril injection The company currently markets Granisetron in 0.1mg/ml, 1ml single dose vials and will commence distributing the 1mg/ml, 1ml single dose, and 1mg/ml, 4ml multiple dose vials immediately.All of APP's Granistron products are said to be...
APP Pharmaceuticals Receives Final Approvals for Additional Dosages of Granisetron Hydrochloride Injection, US - APP Pharmaceuticals, Inc.(Nasdaq:APPX), a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced that it has received final approvals from the U.S.
Food and Drug Administration (FDA) of...
APP wins approval for additional dosages of generic Kytril injection APP Pharmaceuticals has received final approvals from the FDA of its abbreviated new drug applications for Granisetron hydrochloride injection, 1mg/ml, 1ml single dose, and 1mg/ml, 4ml multiple dose vials, the generic equivalent of...
APP Pharmaceuticals Receives Final Approvals for Additional Dosages of Granisetron Hydrochloride Injection, US APP Pharmaceuticals, Inc.(APPX), a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced that it has received final approvals from the U.S.
Food and Drug Administration (FDA) of its...
APP Pharmaceuticals Receives Final Approvals for Additional Dosages of Granisetron Hydrochloride Injection, US APP Pharmaceuticals, Inc.(Nasdaq:APPX), a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced that it has received final approvals from the U.S.
Food and Drug Administration (FDA) of its...
APP Pharmaceuticals Receives Final Approvals for Additional Dosages of Granisetron Hydrochloride Injection, US Author : IL-APP-PHARMACEUTICALS Category : Press Release News Alerts by Email click here ) News | Home SCHAUMBURG, Ill.- (Business Wire) APP Pharmaceuticals, Inc.
(Nasdaq:APPX), a leading manufacturer of multi-source and branded...
APP Pharmaceuticals Receives Final Approvals for Additional Dosages of Granisetron Hydrochloride Injection, US - APP Pharmaceuticals, Inc.(Nasdaq:APPX), a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced that it has received final approvals from the U.S.
Food and Drug Administration (FDA) of...
APP Pharmaceuticals Receives Final Approvals for Additional Dosages of Granisetron Hydrochloride Injection, US AM Eastern Daylight Time Permalink To save a permanent link to this news, right-click the date and time (Ctl-click on a Mac) and choose the command to copy the link, link location or shortcut.Company Now Markets Full Line SCHAUMBURG, Ill....
APP Pharmaceuticals Receives Final Approvals for Additional Dosages of Granisetron Hydrochloride Injection, US APP Pharmaceuticals, Inc.(Nasdaq:APPX), a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced that it has received final approvals from the U.S.
Food and Drug Administration (FDA) of its...
APP Pharma gets FDA final OK for addl Granisetron Hydrochloride Injection doses BOSTON (Thomson Financial) - APP Pharmaceuticals Inc.Thursday said it has received final approvals from the Food and Drug Administration for its abbreviated new drug application for additional dosages of Granisetron Hydrochloride...
APP Pharma gets FDA final OK for addl Granisetron Hydrochloride Injection doses BOSTON (Thomson Financial) - APP Pharmaceuticals Inc.(News) Thursday said it has received final approvals from the Food and Drug Administration for its abbreviated new drug application for additional dosages of Granisetron ...
APP Pharma gets FDA final OK for addl Granisetron Hydrochloride Injection doses BOSTON (Thomson Financial) - APP Pharmaceuticals Inc.Thursday said it has received final approvals from the Food and Drug Administration for its abbreviated new drug application for additional dosages of Granisetron Hydrochloride...
APP Pharma gets FDA final OK for addl Granisetron Hydrochloride Injection doses BOSTON (Thomson Financial) - APP Pharmaceuticals Inc.Thursday said it has received final approvals from the Food and Drug Administration for its abbreviated new drug application for additional dosages of Granisetron Hydrochloride...
APP Pharmaceuticals Receives Final Approvals for Additional Dosages of Granisetron Hydrochloride Injection, US - APP Pharmaceuticals, Inc.(Nasdaq:APPX), a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced that it has received final approvals from the U.S.
Food and Drug Administration (FDA) of...
FDA Approves APP Pharma's Generic Nausea Injection - Top Bid/ASk 18-18.49 (MidnightTrader via COMTEX News Network) -- APP Pharmaceuticals (APPX) has received final approval from the Food and Drug Administration to market its granisetron hydrochloride injection, the generic version of Hoffmann-LaRoche's...
FDA Approves APP Pharma's Generic Nausea Injection - Top Bid/ASk 18-18.49 (MidnightTrader via COMTEX News Network) -- APP Pharmaceuticals (APPX) has received final approval from the Food and Drug Administration to market its granisetron hydrochloride injection, the generic version of Hoffmann-LaRoche's...
APP Pharmaceuticals (APPX) Receives Final Approval for Generic Kytril Sponsored by: StreetInsider Premium - FREE TRIAL!More News related to APPX More News related to FDA APP Pharmaceuticals, Inc!
(Nasdaq: APPX) received final approvals from the FDA of its Abbreviated New Drug Applications (ANDAs) for ...
FDA OKs APP Pharma's generic nausea injection APP Pharmaceuticals Inc.said Thursday it received final approval from the Food and Drug Administration to market its granisetron hydrochloride injection, the generic version of Hoffmann-LaRoche's Kytril injection for chemo-induced...
FDA OKs APP Pharma's generic nausea injection SCHAUMBURG, Ill.- APP Pharmaceuticals Inc.
said Thursday it received final approval from the Food and Drug Administration to market its granisetron hydrochloride injection, the generic version of Hoffmann-LaRoche's Kytril...
FDA OKs APP Pharma's generic nausea injection APP Pharmaceuticals Inc.said Thursday it received final approval from the Food and Drug Administration to market its granisetron hydrochloride injection, the generic version of Hoffmann-LaRoche's Kytril injection for chemo-induced...
Teva Introduces Granisetron Hydrochloride Injection in Multiple Dose Vials Teva Health Systems is pleased to announce the introduction and availability of Granisetron Hydrochloride Injection in 4 mL multiple dose vials.This Teva product is AP rated to Kytril* Injection.
With the addition of this new size...
A.P. Pharma Completes Enrollment in Phase 3 Trial of APF530 - A.P.Pharma, Inc.
(NASDAQ:APPA), a specialty pharmaceutical company, has completed patient enrollment in its pivotal Phase 3 study in chemotherapy-induced nausea and vomiting (CINV) comparing the efficacy of APF530 (a proprietary,...
